A detailed history of Parsifal Capital Management, LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Parsifal Capital Management, LP holds 6,232,971 shares of TEVA stock, worth $140 Million. This represents 9.74% of its overall portfolio holdings.

Number of Shares
6,232,971
Previous 6,696,952 6.93%
Holding current value
$140 Million
Previous $109 Million 3.21%
% of portfolio
9.74%
Previous 10.31%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.81 - $18.96 $7.34 Million - $8.8 Million
-463,981 Reduced 6.93%
6,232,971 $112 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $21.1 Million - $28.7 Million
1,648,652 Added 32.66%
6,696,952 $109 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $53.9 Million - $72.8 Million
5,048,300 New
5,048,300 $71.2 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.9B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Parsifal Capital Management, LP Portfolio

Follow Parsifal Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsifal Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Parsifal Capital Management, LP with notifications on news.